Dr. Chien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1825 Fourth St
Helen Diller Comprehensive Cancer Center
San Francisco, CA 94158Phone+1 415-353-7070Fax+1 415-353-9898- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2006 - 2009
- Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
- Harvard Medical SchoolClass of 2003
Certifications & Licensure
- CA State Medical License 2006 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
- Investigating the Impact of Tamoxifen Therapy on Ovarian Aging Start of enrollment: 2011 Jun 01
- T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer Start of enrollment: 2020 Feb 05
Publications & Presentations
PubMed
- A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.Ozge Gumusay, Laura A Huppert, Mark Jesus M Magbanua, Chiara A Wabl, Michael Assefa, Amy Jo Chien, Michelle E Melisko, Melanie C Majure, Mark Moasser, John Park, Hope ...> ;Breast Cancer Research and Treatment. 2024 Jan 1
- Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.Saya Jacob, MacKenzie Johnson, Brianna Roque, Laura Quintal, Hope S Rugo, Michelle Melisko, Amy Jo Chien> ;Clinical Breast Cancer. 2023 Oct 1
- 1 citationsOutcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast c...Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, A Jo Chien, Judy C Boughey, Hyo S Han, Anne Wallace, Heather Beckwith, Minetta C Liu, Christina Yau, E Paul Wile...> ;Breast Cancer Research and Treatment. 2023 Apr 1
- Join now to see all
Lectures
- A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast canc...2019 ASCO Annual Meeting - 6/1/2019
- UCSF Asian Health SymposiumUniversity of California, San Francisco, California - 2/9/2012
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: